###begin article-title 0
Endothelial-specific ablation of Serum Response Factor causes hemorrhaging, yolk sac vascular failure, and embryonic lethality
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 720 727 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 727 728 727 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 736 741 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2 </italic>
###xml 791 795 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 850 854 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 860 863 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 863 864 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 865 866 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 863 866 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f</italic></sup>
###xml 623 638 <span type="species:ncbi:10090">transgenic mice</span>
###xml 687 691 <span type="species:ncbi:10090">Mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
Serum response factor (SRF), a member of the MADS box family of nuclear transcription factors, plays an important role in cardiovascular development and function. Numerous studies demonstrate a central role for SRF in regulating smooth and cardiac muscle cell gene expression. Consistent with this, loss of SRF function blocks differentiation of coronary vascular smooth muscle cells from proepicardial precursors, indicating SRF is necessary for coronary vasculogenesis. The role of SRF in endothelial cell contribution during early vascular development, however, has not been addressed. To investigate this, we generated transgenic mice lacking expression of SRF in endothelial cells. Mice expressing Cre recombinase (Tie2Cre+) under Tie2 promoter control were bred to mice homozygous for Srf alleles containing loxP recombination sites within the Srf gene (Srff/f). Tie2 is a tyrosine kinase receptor expressed predominantly on endothelial cells that mediates signalling during different stages of blood vessel remodelling. Resulting embryos were harvested at specific ages for observation of physical condition and analysis of genotype.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 157 159 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 155 159 155 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 359 362 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 365 366 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 367 369 367 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 365 369 365 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
Tie2Cre+/-Srff/f embryos appeared to develop normally compared to wild-type littermates until embryonic day 10.5 (E10.5). Beginning at E11.5, Tie2Cre+/-Srff/f embryos exhibited cerebrovascular hemorrhaging and severely disrupted vascular networks within the yolk sac. Hemorrhaging in mutant embryos became more generalized with age, and by E14.5, most Tie2Cre+/-Srff/f embryos observed were nonviable and grossly necrotic. Hearts of mutant embryos were smaller relative to overall body weight compared to wild-type littermates. Immunohistochemical analysis revealed the presence of vascular endothelial cells; however, vessels failed to undergo appropriate remodelling. Initial analysis by electron microscopy suggested a lack of appropriate cell-cell contacts between endothelial cells. Consistent with this, disrupted E-cadherin staining patterns were observed in mutant embryos.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
These results provide the first in vivo evidence in support of a role for SRF in endothelial cell function and strongly suggest SRF is required for appropriate vascular remodelling.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 228 229 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1037 1038 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 852 855 <span type="species:ncbi:9860">Elk</span>
Serum response factor (SRF) is a nuclear transcription factor of the MADS (MCM1, Agamous, Deficiens, SRF) box family. SRF interacts as a dimer with DNA at the serum response element (SRE), a 10 base pair AT-rich sequence [CC(AT)6GG] also known as the CArG box (for review see [1,2]). The SRE sequence is present in a wide variety of genes, including those encoding for immediate early proteins (e.g. Fos, Jun, HSP70), neuronal nuclear receptors (e.g. Nurr1, Nur77) and numerous contractile and cytoskeletal proteins (eg. actins, myosins). Expression of SRF is essential in early development as SRF-null embryos die during gastrulation [3]. SRF is required for development of mesoderm [3]. The expression pattern of genes under SRF control is regulated in a combinatorial fashion by SRF's ability to interact with a variety of accessory factors such as Elk-1 and SAP-1 to regulate expression of genes involved in cell growth and proliferation, and myocardin and related family factors to control myogenic gene expression (for review see [4]).
###end p 9
###begin p 10
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 574 582 574 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
SRF plays a critical role in myogenesis. Early studies established the expression of SRF in cells of the myogenic lineage [5-7], and SRF has been shown to be required for appropriate skeletal, cardiac and smooth muscle cell growth and differentiation [8,9]. SRF gene knockout studies from our laboratory indicate that disruption of SRF in cardiomyocytes leads to severe defects in the contractile apparatus, including Z-disc and stress fiber formation, as well as mislocalization and/or attenuation of sarcomeric protein expression [10]. Consistent with these observations, in vivo cardiovascular-specific knockout of SRF results in embryonic death via cardiovascular failure due to perturbations in normal muscle cytoarchitecture and contractile assembly [11-13]. Numerous studies suggest that disordered myogenic gene expression is due to defective SRF-mediated regulation of the smooth muscle cell-specific regulatory factor myocardin [14-16].
###end p 10
###begin p 11
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
SRF is a key regulator in development of the coronary vasculature. Coronary vasculature is derived from a transient embryonic structure termed the proepicardium (PE) [17-19]. The PE is characterized as a small, grape cluster-like aggregate of cells developing at embryonic day 9 (E9) from an extension of the septum transversum, lying beneath the developing heart tube [20]. Cells of the PE undergo an epithelial-to-mesenchymal transition (EMT) and migrate over the surface of the heart. Some cells form the primitive epicardium, and others appear to continue to infiltrate into the subepicardial space. Once dispersed into the heart tissue, these subepicardial mesenchymal cells (SEMC) differentiate into the vascular smooth muscle cells (VSMC) and vascular endothelial cells (VEC) that comprise the coronary vasculature [18]. Previous work in our laboratory has demonstrated expression of SRF within cells of the PE and newly formed coronary vessels [21]. Landerholm and colleagues [22] have shown that inhibitory SRF constructs block differentiation of avian PE to VSMC, indicating a central role for SRF in differentiation of PE-derived cells to VSMC.
###end p 11
###begin p 12
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 418 427 418 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
A role for SRF in differentiation and function of VSMC is well established, however, little is known about the role of SRF in VEC [5,23]. Using primary HUVEC cultures, Chai and colleagues [24] have shown that vascular endothelial growth factor (VEGF) signalling pathways require SRF. Endothelial cells in which SRF has been knocked down fail to respond to intercellular VEGF signalling and show abolished VEGF-induced in vitro angiogenesis, impaired endothelial cell migration and proliferation, and inhibited VEGF-induced actin polymerization and immediate early gene expression.
###end p 12
###begin p 13
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 345 346 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 347 348 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 345 348 345 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f</italic></sup>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2 </italic>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 451 454 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 604 612 604 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 767 774 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 774 777 774 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 777 780 777 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 780 781 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 782 783 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 780 783 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f</italic></sup>
###xml 1752 1760 1752 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 311 315 <span type="species:ncbi:10090">Mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
These studies indicate that SRF likely plays an important role in endothelial cell function. The in vivo role of endothelial SRF, however, has not been addressed. Therefore, in the current study we investigated the role of SRF in VEC function by carrying out endothelial cell-specific ablation of the SRF gene. Mice homozygous for Srf-Lox P (Srff/f) alleles were bred to mice expressing the Cre recombinase protein under Tie2 promoter control (Tie2Cre+/-). Tie2 is a vascular endothelial-specific tyrosine kinase receptor for the angiopoietin family of vascular remodelling factors [25,26]. The onset of Tie2Cre expression is concurrent with the appearance of endothelium in E7.5 embryos and continues in adult tissues [27]. In embryos expressing the mutant genotype Tie2Cre+/-Srff/f, we observed hemorrhaging by E11.5 and near complete lethality by E14.5. Examination of cardiac morphology revealed smaller hearts as well as mild ventricular-septal defects in mutant embryos as compared to wild-type littermates. Immunohistochemical analysis suggests VEC properly differentiated and assembled blood vessels. However, the appearance of blood pools and segmented blood vessels observed in embryos and yolk sacs of E11.5-E13.5 embryos indicated disrupted vascular networks consistent with a defect in vascular remodelling. Further analysis of yolk sac tissues by electron microscopy demonstrated a lack of desmosomal-type junction complexes as well as a paucity of collagen matrix between the endodermal and mesodermal cell layers. E-cadherin protein detected by immunofluorescence showed a dramatic decrease in signal along the apical brush-border of endothelial cells in the extraembryonic endodermal layer in yolk sac. These results provide the first in vivo evidence in support of a role for SRF in endothelial cell function and strongly suggest SRF is required for appropriate vascular remodelling.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Conditional ablation of SRF protein in endothelium causes hemorrhaging in developing embryos
###end title 15
###begin p 16
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/+ </sup>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 59 60 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 61 63 61 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 328 335 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 335 338 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 343 345 343 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 341 345 341 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 476 481 476 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D, F</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1H</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1H</xref>
###xml 707 708 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 792 799 792 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 799 802 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 802 805 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 805 806 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 807 809 807 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 805 809 805 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 857 858 857 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
Inspection of embryos harvested from Tie2Cre+/-Srff/+ x Srff/f matings revealed internal hemorrhaging and blood pooling consistent with loss of vascular organization (see Figures 1 and 2). Mutant embryos appeared to develop normally until E10.5 (compare Fig. 1A and 1B). However, by E11.5 embryos expressing the mutant genotype Tie2Cre+/-Srff/f began to exhibit internal hemorrhaging (Fig. 1D, arrowhead). The extent of bleeding continued to progress with embryonic age (Fig. 1D, F, &1H). Wild-type littermates showed intact vascular formation in contrast to mutant embryos (compare Fig. 1G and 1H). Upon closer examination, loss of vascular formation in the mutant embryos becomes more obvious (see Figure 2). A striking difference in the lack of apparent intact vasculature was observed in Tie2Cre+/-Srff/f embryos compared to wild-type littermates (Fig. 2, compare arrows in A and B, C and D, E and F, and G and H). Blood pooling noted in mutant embryos (Fig. 2B and 2F, asterisks) supports a loss of vascular integrity.
###end p 16
###begin p 17
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>embryos exhibit internal hemorrhaging</bold>
###xml 172 179 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 187 189 187 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 185 189 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Tie2Cre+/-Srff/f embryos exhibit internal hemorrhaging. Photographs of whole unfixed, unstained mouse embryos at E10.5 (A, B), E11.5 (C, D), E12.5 (E, F) and E13.5 (G, H). Tie2Cre+/-Srff/f mutant embryos (B, D, F, H) exhibited internal hemorrhaging compared to wild-type littermates (A, C, E, G). This effect progressed with increasing gestational age. E14.5 mutant embryos were grossly necrotic and unsuitable for analysis. Labelled boxes in Fig. 1 correspond to images in Fig. 2.; Lv = liver. Arrowhead marks minimal hemorrhaging observed in E11.5 embryos.
###end p 17
###begin p 18
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 67 69 67 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 65 69 65 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Vascular fragmentation and internal hemorrhaging in <italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>embryos</bold>
###xml 224 231 224 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 234 237 234 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 239 241 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 237 241 237 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
Vascular fragmentation and internal hemorrhaging in Tie2Cre+/-Srff/f embryos. Higher magnification photographs of whole unfixed, unstained mouse embryos as in Figure 1; embryos were examined at E12.5 (A, B) and E13.5 (C-H). Tie2Cre+/-Srff/f mutant embryos (B, D, F, H) exhibited blood pooling (asterisks) and loss of visible vascular structures (arrowheads mark similar vessels; compare A & B, C & D, E & F, and G & H).
###end p 18
###begin title 19
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
Endothelial-specific disruption of the Srf gene during development causes embryonic lethality
###end title 19
###begin p 20
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 453 460 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 460 463 460 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 463 466 463 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 468 470 468 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 466 470 466 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
The effect of endothelial-specific conditional ablation of SRF protein expression during embryonic development was evaluated. Loss of SRF expression in endothelial cells was achieved by Tie2 driven-Cre recombinase-mediated excision of the promoter region and first exon of Srf [11]. The conditional loss of Srf gene function in endothelial cells resulted in embryonic death by E14.5 (see Table 1). The majority of animals expressing the mutant genotype Tie2Cre+/-Srff/f displayed an abnormal phenotype, and all necrotic embryos collected expressed the mutant genotype. No animals with a mutant genotype were detected in late gestation or at birth.
###end p 20
###begin p 21
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2&#183;Cre</italic>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 45 47 45 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
Embryos with mutant genotype Tie2.Cre+/-Srff/f die by E14.5
###end p 21
###begin p 22
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 71 75 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/+ </sup>
###xml 90 93 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 95 97 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 93 97 93 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Genotypic analysis of mouse embryos generated by crossing Tie2Cre+/-Srff/+ male mice with Srff/f female mice. Numbers represent total embryos of each genotype; numbers in parentheses indicate mutant phenotype and grossly necrotic embryos. The conditional loss of Srf gene function in endothelial cells resulted in embryonic death by E14.5; no animals with mutant genotype were detected during late gestational age or at birth.
###end p 22
###begin title 23
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f/f </italic>
###xml 23 27 23 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f/f </italic></sup>
Hearts of Tie2Cre+/-Srff/f mutant embryos are smaller
###end title 23
###begin p 24
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 634 636 634 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 632 636 632 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
Since SRF plays a central role in cardiac development, we examined cardiac morphology of mutant embryos and their wild-type littermates to ascertain whether observed embryonic lethality was due to abnormal cardiac morphogenesis. Embryos harvested from timed-pregnant female mice were subjected to fixation for analysis of morphology or for quantification of whole body and isolated heart weights. Hearts of wild-type embryos correctly formed atrial and ventricular chambers, and major vessels of the atrial tree were present (see Figure 3). In contrast, the muscular portion of the interventricular septum in hearts of Tie2Cre+/-Srff/f mutant genotype embryos appeared reduced (Fig. 3B and 3D), potentially resulting in ventricular-septal defects. Furthermore, enlarged vessels were observed in mutant embryos, presumably due to edema caused by vascular insufficiency (Fig. 3B and 3D, asterisks). Analysis of endocardial cushion extracellular matrix deposition revealed no difference between wild-type and mutant littermates (alcian blue staining; data not shown).
###end p 24
###begin p 25
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hearts in mutant embryos are smaller and dysmorphic</bold>
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 192 195 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 198 202 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Hearts in mutant embryos are smaller and dysmorphic. Photomicrographs (40x) of transverse sections of mouse embryos at E12.5 (A, B) and E13.5 (C, D) stained with hematoxylin and eosin. Tie2Cre+/-Srff/f embryos exhibited reduced heart size by E12.5 (B, compare to A), which became more pronounced and consistent at E13.5 (D, compare to C). (E) Quantitation of heart size normalized to overall body weight revealed smaller hearts in both E12.5 (1.5 +/- 0.4 vs. 1.08 +/- 0.5, wild-type vs. mutant respectively; p = 0.054) and E13.5 embryos (1.4 +/- 0.39% vs. 1.04 +/- 0.17%, wild-type vs. mutant respectively; p = 0.021). Enlarged vessels apparently caused by edema due to vascular insufficiency were also noted in mutant embryos (asterisks). LV = left ventricle. Scale bar: 200 mum.
###end p 25
###begin p 26
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 900 901 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Hearts of mutant embryos appeared smaller than those of wild-type littermates. To assess this observation, whole body and isolated heart weights from E12.5 and E13.5 embryos were used to calculate heart weights as a percentage of overall body weight (Fig. 3E). The decrease in apparent size of mutant hearts appeared as early as E12.5 (compare Fig. 3A with 3B); however, differences in whole body and heart weights at this age did not reach statistical significance (1.5 +/- 0.4 vs. 1.08 +/- 0.5, wild-type vs. mutant respectively; p = 0.054). Normalized heart weights from E13.5 mutant embryos were reduced (1.4 +/- 0.39% vs. 1.04 +/- 0.17%, wild-type vs. mutant respectively; p = 0.021). Furthermore, immunofluorescent analysis of phosphorylated histone H3 in E11.5 embryos revealed an apparent reduction in the number of endocardial endothelial cells undergoing proliferation (see Additional file 1); no difference in apoptotic activity was detected (cleaved caspase 3 immunofluorescent analysis; data not shown). In contrast, the ratio of cardiomyocytes to total cells was not different between wild-type and mutant heart tissues (MF-20-immunolabelled cells as a percentage of total DAPI-positive nuclei; data not shown), suggesting that the heart size differences noted are not due to a selective loss of cardiomyocytes. E14.5 embryos with mutant genotype were grossly necrotic and unsuitable for analysis.
###end p 26
###begin title 27
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f/f </italic>
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f/f </italic></sup>
Yolk sac vasculature fails in Tie2Cre+/-Srff/f mutant embryos
###end title 27
###begin p 28
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 396 401 396 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B, C</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4H</xref>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 681 686 681 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A, C</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 700 705 700 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B, D</xref>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F</xref>
The Tie2Cre construct is expressed in blood islands and hemangioblasts within the extraembryonic yolk sac as early as E7.5 [27]. Ablation of SRF protein expression in yolk sac endothelial tissues caused blood vessel disorganization and subsequent vascular failure (see Figures 4 and 5). Yolk sac blood vessels appeared normal in both wild-type and mutant animals until E11.5 (compare Fig. 4A and 4B, C and 4D). In contrast, the yolk sacs of E12.5 and E13.5 mutant embryos contained blood pools and fragmented blood vessels (Fig. 4F and 4H), consistent with impaired vascular remodelling. Closer examination revealed a web of poorly organized vessels (Fig. 5, compare arrowheads in 5A, C, and 5E with 5B, D, and 5F).
###end p 28
###begin p 29
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>embryos exhibit yolk sac vascular failure</bold>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 232 234 232 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 230 234 230 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
Tie2Cre+/-Srff/f embryos exhibit yolk sac vascular failure. Photographs of whole unfixed, unstained intact yolk sacs containing mouse embryos at E10.5 (A, B), E11.5 (C, D), E12.5 (E, F) and E13.5 (G, H). Embryos with Tie2Cre+/-Srff/f genotype exhibited severely disrupted vascular networks at E12.5 (F) and E13.5 (H) as compared to wild-type littermates (E and G respectively). Labelled boxes in Fig. 4 correspond to images in Fig. 5.
###end p 29
###begin p 30
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 33 34 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 35 37 35 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 33 37 33 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Yolk sac tissues of <italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>embryos display vascular disintegration and blood pooling</bold>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
Yolk sac tissues of Tie2Cre+/-Srff/f embryos display vascular disintegration and blood pooling. Photographs of whole unfixed, unstained intact yolk sacs containing mouse embryos at E12.5 (A, B, C, D) and E13.5 (E, F). Yolk sac tissues from mutant embryos showed disorganized vascular networks at E12.5 (B) that become more pronounced at E13.5 (D, F arrowheads). Blood pools (B, asterisks) were also observed in mutant yolk sac tissues.
###end p 30
###begin title 31
SRF protein is localized within endothelial cells
###end title 31
###begin p 32
###xml 272 279 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 282 285 282 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 285 286 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 287 289 287 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 285 289 285 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
To establish the expression of SRF within VEC of the coronary vasculature, we performed double-label immunofluorescent analysis of embryonic mouse heart. Ventricular tissue was isolated from wild-type E16.5 mouse embryos, after coronary vessels have formed; corresponding Tie2Cre+/-Srff/f samples were not obtainable as affected embryos die by E14.5. Sections of paraffin-embedded ventricular tissue were immunolabelled for both PECAM-1 and SRF proteins and examined by confocal laser microscopy (see Figure 6). PECAM-1-stained endothelial cells were clearly visible surrounding vessels in ventricular myocardium as well as surrounding the myocardial wall (Fig. 6A, arrowheads). Cardiomyocytes showed robust SRF staining (Fig. 6A, asterisks). Higher magnification imaging of a single focal plane showed nuclear-localized SRF immunostaining (Fig. 6B, asterisks) surrounded by PECAM-1 labelled endothelial cell membranes (Fig. 6B, arrowheads).
###end p 32
###begin p 33
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Detection of SRF protein within vascular endothelial cells</bold>
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
Detection of SRF protein within vascular endothelial cells. Single-plane confocal laser photomicrographs (A-630x, B-1,000x) of ventricular tissue from wild-type E16.5 mouse heart immunolabelled with the VEC marker PECAM-1 (red) and SRF (green). (A) PECAM-1-stained cells surround vessels as well as form the epicardium (arrowheads). Cardiomyocytes within ventricular tissue show strong SRF staining (asterisks). (B) Endothelial cell-specific PECAM-1 (red; arrowheads) encircles the nuclear-localized SRF protein (green; asterisks). Scale bars: A = 40 mum; B = 4 mum.
###end p 33
###begin title 34
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f/f </italic>
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f/f </italic></sup>
SRF protein is decreased in VEC from Tie2Cre+/-Srff/f embryos
###end title 34
###begin p 35
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 848 850 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
We analyzed embryonic vascular tissues using double-label immunofluorescence microscopy to verify the loss of SRF protein in affected cells (see Figure 7). Tissues from E10.5 wild-type (Fig. 7A and 7B) and mutant (Fig. 7C and 7D) embryos were labelled with antibodies against SRF and the VEC-marker PECAM-1 and analyzed by confocal laser microscopy. Single-plane confocal images of blood vessels were used to count the total number of VEC and the number of VEC exhibiting SRF. Only those cells showing SRF signal completely encircled by PECAM-1 staining were scored as SRF-positive VEC (Fig. 7B, arrowhead). Final numbers were expressed as percent SRF-positive VEC of the total counted for that vessel. A high proportion of VEC in wild-type vessels were positive for SRF (84% +/- 14.3) compared to mutant vessels (25% +/- 15.7; p < 0.0000004; Fig. 7E).
###end p 35
###begin p 36
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 66 68 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SRF protein is decreased in endothelial tissues of <italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>embryos</bold>
###xml 906 908 902 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
SRF protein is decreased in endothelial tissues of Tie2Cre+/-Srff/f embryos. Photomicrographs (A, C:1,000x; B, D:4,000x) of cross-sections of blood vessels from E10.5 wild-type (A, B) and mutant (C, D) embryos were used to count the total number of VEC and the number of VEC exhibiting SRF (boxes in A, C correspond to images in C, D respectively). Tissues were labelled with antibodies against SRF (green) and the VEC-marker PECAM-1 (red) and analyzed using single-plane confocal laser microscopy (blue = Topro3 nuclear staining). Only those cells showing SRF signal completely encircled by PECAM-1 staining were scored as SRF-positive VEC (B, D arrowheads). Not all VEC displayed detectable SRF protein (A, arrow). Final numbers were expressed as percent SRF-positive VEC of the total counted for that vessel (E): 84 +/- 14.3 vs. 25 +/- 15.7, wild-type vs. mutant respectively; *p = 0.0000004, student's t test. Scale bars: A, C = 30 mum; B, D = 10 mum.
###end p 36
###begin p 37
###xml 10 18 10 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
Since the Tie2Cre construct has been shown to be expressed in endocardial endothelial cells, we analyzed embryonic ventricular tissue for the presence or absence of SRF protein using single-plane confocal images as described above (see Additional file 2). We found a higher number of endocardial endothelial cells exhibiting SRF-positive immunofluorescence in wild-type as compared to mutant tissues. No significant change in expression of SRF protein was observed between wild-type or mutant embryos in the epicardium (Additional file 2). Furthermore, to verify that SRF protein expression in cardiomyocytes was not grossly affected by loss of SRF in endothelial cells, we analyzed SRF protein expression in embryonic heart tissues by immunodetection; however, no differences were noted (Additional file 2).
###end p 37
###begin title 38
Early coronary vessel formation appears normal in mutant embryos
###end title 38
###begin p 39
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 363 370 363 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 370 373 370 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 373 376 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 376 377 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 378 380 378 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 376 380 376 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 525 532 525 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 532 535 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 535 538 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 538 539 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 540 542 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 538 542 538 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
Coronary vessels begin to form at approximately E11.5, with the coronary vascular network complete by E16.5 [28]. We examined early coronary vessel formation by whole-mount immunohistochemical analysis of hearts from E12.5 embryos (see Figure 8). We used the VEC-specific cell-surface marker PECAM-1 to label vascular structures in hearts from both wild-type and Tie2Cre+/-Srff/f embryos. Vessels on the external ventral (Fig. 8A and 8B) and dorsal (Fig. 8C and 8D) surfaces are visible and seem intact in both wild-type and Tie2Cre+/-Srff/f embryos. This observation indicates that initial formation of the coronary vasculature is not affected by loss of SRF in endothelial cells. However, we were unable to complete assessment of the angiogenic remodelling responsible for maturation of the coronary vascular network in mutant embryos as they die and become grossly necrotic by E14.5.
###end p 39
###begin p 40
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 52 54 52 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Early coronary vessel development in <italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>embryos appears normal compared to wild-type littermates</bold>
###xml 174 181 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 189 191 189 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 187 191 187 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
Early coronary vessel development in Tie2Cre+/-Srff/f embryos appears normal compared to wild-type littermates. Photographs of whole-mount immunostained wild-type (A, C) and Tie2Cre+/-Srff/f (B, D) hearts. Samples were stained with the endothelial cell marker PECAM-1 to detect vascular structures. Vessels on ventral (A, B) and dorsal (C, D) heart surfaces were clearly visible, indicating apparently normal assembly of initial coronary vasculature. LV = left ventricle.
###end p 40
###begin title 41
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f/f </italic>
###xml 35 39 35 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f/f </italic></sup>
Yolk sac tissues from Tie2Cre+/-Srff/f embryos retain VEC despite fragmentation of blood vessels
###end title 41
###begin p 42
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 434 441 434 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 441 444 441 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 444 447 444 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 449 451 449 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 447 451 447 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
The Tie2Cre construct is expressed in endodermal tissue layers of the yolk sac as well as in VEC. Yolk sac vascular networks undergo extensive remodelling during the course of embryogenesis. Based on our observation of fragmented yolk sac vessels, we sought to determine the status of VEC within yolk sac tissues. We looked for the presence of VEC within yolk sac tissues by immunolabelling whole mount samples of E13.5 wild-type and Tie2Cre+/-Srff/f yolk sac tissues with the VEC marker PECAM-1 (see Figure 9). Yolk sac tissues from embryos lacking SRF in endothelium demonstrated the presence of appropriately differentiated VEC; however, blood vessels in SRF-null yolk sac tissues were almost completely disintegrated by this age. Remnants of presumed blood vessels could still be seen (Fig. 9B, arrowheads), suggesting incomplete vessel remodelling or inappropriate maintenance of existing vessels.
###end p 42
###begin p 43
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>yolk sac tissues show loss of blood vessel integrity and separation of dermal layers</bold>
###xml 252 259 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 259 262 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 267 269 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 265 269 265 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 446 449 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 449 452 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 454 456 454 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 452 456 452 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 780 787 780 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 790 793 790 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 793 794 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 795 797 795 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 793 797 793 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
Tie2Cre+/-Srff/f yolk sac tissues show loss of blood vessel integrity and separation of dermal layers. Yolk sac tissues immunostained with VEC-specific marker PECAM-1 to label endothelial cells and vascular structures. Photographs of wild-type (A) and Tie2Cre+/-Srff/f (B) whole yolk sac at E13.5; arrowheads (B) mark apparent blood vessel remnants in mutant yolk sac tissue. Photomicrographs (200x) of cross-sections of wild-type (C) and Tie2Cre+/-Srff/f (D and E) yolk sac at E13.5 immunolabelled for PECAM-1 (brown-gray = PECAM-1, red = neutral red counterstain). Normal cellular layers of endoderm (Ed) and extraembryonic mesoderm (Md) are tightly associated in wild-type as compared to mutant yolk sac tissue. Asterisks mark areas of inappropriate tissue layer separation in Tie2Cre+/-Srff/f yolk sac (D). (E) Quantitation of laminar separation in cross-sections of yolk sac tissues as in C and D revealed increased delamination in mutant animals (16.3 +/- 10.8% vs. 62.0 +/- 10.4%, wild-type vs. mutant respectively; p = 0.0031). Scale bar: C, D = 50 mum.
###end p 43
###begin p 44
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 59 61 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9E</xref>
Furthermore, cross-sectional examination of Tie2Cre+/-Srff/f yolk sac tissues revealed delamination of the endodermal and mesodermal components of the yolk sac layers (Fig. 9C and 9D). Tissues immunolabelled by the VEC marker PECAM-1 showed separation of the endodermal and mesodermal tissues (compare Fig. 9C and 9D, asterisks). Also, some areas of laminar separation were observed to contain blood cells, suggesting these areas derived from either blood vessels or blood islands. Quantitation of the linear length of laminar separation in cross-sections shows that yolk sac tissues from mutant animals have a greater degree of laminar separation than wild-type littermates (see Fig. 9E; 16.3 +/- 10.8% vs. 62.0 +/- 10.4% wild-type vs. mutant; p = 0.003).
###end p 44
###begin title 45
Mutant yolk sac tissues lack cell-cell junctions and intra-laminar collagen deposition
###end title 45
###begin p 46
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 62 64 62 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 60 64 60 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 236 243 236 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 243 246 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 251 253 251 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 249 253 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 267 270 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10B</xref>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10E</xref>
###xml 450 453 450 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10C</xref>
###xml 483 486 483 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10F</xref>
Samples of yolk sac tissues from wild-type and Tie2Cre+/-Srff/f embryos were processed for analysis by transmission electron microscopy (see Figure 10). Wild-type tissues contained desmosomal-type junction complexes that were absent in Tie2Cre+/-Srff/f tissues (Fig. 10B, arrowheads; compare to Fig. 10E). Furthermore, collagen deposition in the extracellular matrix between the endodermal and mesodermal yolk sac layers was greatly diminished (Fig. 10C, arrowheads; compare to Fig. 10F). Sub-cellular elements of both endodermal and mesodermal cells in mutant tissue appeared largely normal, and did not display signs of necrosis nor apoptotic bodies. This observation suggests that the loss of cell-cell adhesion complexes is not due to gross disintegration of the yolk sac tissue as a whole, but rather is a consequence of SRF deprivation.
###end p 46
###begin p 47
###xml 0 113 0 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lack of junctional complexes and collagen deposition revealed by electron microscopy analysis of yolk sac tissues</bold>
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 174 175 174 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 176 178 176 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 174 178 174 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
Lack of junctional complexes and collagen deposition revealed by electron microscopy analysis of yolk sac tissues. Yolk sac tissues from wild-type (A, B, C) and Tie2Cre+/-Srff/f (D, E, F) embryos were subjected to transmission electron microscopy to assess ultrastructural detail. Desmosomal-type junctional complexes are observed in wild-type tissue (B arrowheads) but not in mutant tissue (E). Intralaminar collagen deposition occurs normally between endodermal and mesodermal cell layers in wild-type (A, C) but not mutant (D, F) tissues. Arrowheads in C denote longitudinal and cross-sectional views of individual collagen fibrils. Boxes in A and D correspond to images in B and E, respectively; asterisks in A and D correspond to images in C and F, respectively; scale bars: A, D = 1 mum; B, C, E, F = 0.2 mum.
###end p 47
###begin title 48
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f/f </italic>
###xml 40 44 40 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f/f </italic></sup>
E-Cadherin is decreased in Tie2Cre+/-Srff/f embryonic yolk sac tissues
###end title 48
###begin p 49
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 165 168 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 171 175 171 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 499 502 499 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11A</xref>
###xml 507 510 507 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11B</xref>
###xml 619 622 619 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11C</xref>
###xml 627 630 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11D</xref>
We sought to confirm our electron microscopy observations by immunofluorescent labelling of junctional complexes by E-cadherin (see Figure 11). Wild-type and Tie2Cre+/-Srff/f yolk sac tissues were double-labelled with the endothelial cell marker PECAM-1 and E-cadherin and subjected to fluorescent microscopy for analysis. Wild-type endodermal cells displayed intense E-cadherin localization along the apical brush-border surface, a staining pattern largely absent from mutant tissues (compare Fig. 11A and 11B). Closer examination by confocal laser microscopy confirmed the lack of detectable E-cadherin (compare Fig. 11C and 11D, arrowheads).
###end p 49
###begin p 50
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 75 77 75 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E-Cadherin localization is disrupted in yolk sac tissues of <italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>embryos</bold>
###xml 516 523 516 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 523 526 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 529 530 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 531 533 531 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 529 533 529 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
E-Cadherin localization is disrupted in yolk sac tissues of Tie2Cre+/-Srff/f embryos. Photomicrographs of wild-type (A, C; 400x) and mutant (B, D; 2,000x) yolk sac tissues stained for PECAM (red) and E-cadherin (green). Immunofluorescent analysis revealed a decrease in detectable E-cadherin protein in mutant samples. Robust E-cadherin staining is observed in the endodermal (Ed) but not mesodermal (Md) layer of wild-type yolk sac (A). In contrast, very little E-cadherin staining can be detected in yolk sac from Tie2Cre+/-Srff/f embryos (B). Single-plane confocal microscopy (C, D; 4,000x) confirms the lack of E-cadherin immunostaining at the apical brush-border surface of mutant yolk sac endodermal cells (compare A and B, arrowheads). Blue stain in A and B is DAPI nuclear stain. Scale bars: A, B = 50 mum; C, D = 7.5 mum.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 649 656 649 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 815 819 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2</italic>
###xml 863 867 863 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
Numerous studies have shown that SRF is a critical transcriptional regulator of genes important for VSMC differentiation and development, and therefore a key regulator of vascular development. Consistent with this, SRF is required for differentiation of PE-derived precursors to VSMC during coronary vascular development [22]. We have previously shown, however, that SRF is expressed in the PE prior to detectable expression of VSMC markers [21], raising the possibility that SRF may play a role in differentiation of PE-derived coronary VEC as well. To begin to address this idea, we have sought to investigate the role of SRF in endothelial cells in vivo, and whether endothelial SRF is required for normal vascular development. Towards that end, we crossed mice expressing Cre recombinase under the VEC-specific Tie2-derived promoter with mice carrying floxed Srf alleles. Our data demonstrate that SRF plays a crucial role in appropriate VEC function beginning early in embryonic development.
###end p 52
###begin p 53
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 123 126 123 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 128 130 128 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 126 130 126 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 678 686 678 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 819 823 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1203 1205 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1412 1419 1412 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 1419 1422 1419 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1422 1425 1422 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 1425 1426 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 1427 1429 1427 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 1425 1429 1425 1429 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
Mutant embryos lacking SRF expression in VEC die by E14.5. Examination of heart structure reveals that hearts of Tie2Cre+/-Srff/f embryos undergo looping and chamber formation; however, hearts of mutant embryos are measurably smaller with increasing gestational age compared to wild-type littermates. We did not detect a difference in the percentage of cardiomyocytes in heart tissue between wild-type and mutant embryos despite noting a small decrease in cardiomyocyte proliferation. Analysis of apoptotic activity by cleaved caspase 3 immunoreactivity also showed no discernible difference between wild-type and mutant embryos. Based on the well-documented specificity of the Tie2Cre driver, it is unlikely that the small decrease in cardiomyocyte proliferation observed is due to direct Cre-mediated excision of the Srf allele in cardiomyocytes [27]. One possible explanation for the reduction in cardiomyocyte proliferation in mutant embryos is that there is a defect in signalling to cardiomyocytes. In support of this idea, a variety of studies have demonstrated the importance of reciprocal signalling pathways between endocardial endothelial cells and the developing myocardium (for review see [29]). This raises the possibility that impaired signalling from SRF-null endocardial endothelial cells is contributing to reduced cardiomyocyte proliferation and the overall decrease in heart size observed in Tie2Cre+/-Srff/f embryos. The apparent reduction in endocardial cell proliferation we observed in mutant embryos further suggests that loss of SRF in endothelial cells results in impaired endocardial endothelial cell function; however, which endothelial signalling pathways are impaired in SRF-null cells remains to be determined.
###end p 53
###begin p 54
###xml 182 191 182 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in utero </italic>
Endocardial cushion tissues are present; however, septal tissues appear poorly formed in mutant embryos, and in some cases exhibit a failure to form ventricular septa. Nevertheless, in utero lethality lacking gross defects in heart structure supports the idea of vascular failure as a cause of death. Lethal vessel malfunction may be occurring within the atrial tree, embryonic or extra-embryonic vasculature, or yolk sac vasculature. Consistent with this, mutant embryos exhibit hemorrhaging within the head, abdomen, and limbs as early as E12.5, a time when blood vessel remodelling is occurring. Yolk sac vasculature is also disrupted, suggesting a common mechanism of vessel malfunction in both embryonic and extra-embryonic tissues.
###end p 54
###begin p 55
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 568 576 568 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 892 896 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1172 1181 1172 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Initial vessel formation in the heart begins at approximately E11.5 and is completed with establishment of mature coronary arteries by E16.5 [28]. Early coronary vasculogenesis appears to occur normally in embryos lacking SRF in VEC as shown by the presence of PECAM-1-positive vessels in hearts from both wild-type and mutant E12.5 embryos. Nevertheless, mutant embryos die by E14.5, leaving the issue of SRF's role in coronary vasculature remodelling and maturation unclear. Determining the precise requirement for SRF in VEC specification is also complex since the Tie2Cre construct begins expression presumably after hemangioblast specification. Examination of blood smears from E12.5 embryos reveals no grossly observable differences between wild-type and mutant samples (data not shown). This may suggest that early VEC progenitors in the yolk sac are not influenced by excision of the Srf gene; however since the SRF protein has a relatively long half-life [30], we cannot rule out the possibility that residual SRF protein levels remain sufficient to sustain specification and differentiation of early VEC. These questions are better suited to investigation using in vitro model systems of VEC specification and differentiation, and are the object of ongoing studies.
###end p 55
###begin p 56
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 134 137 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 142 144 142 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 140 144 140 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 397 400 397 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
While it is evident that SRF protein levels are reduced in VEC of mutant embryos, detectable SRF protein in both wild-type and Tie2Cre+/-Srff/f embryos suggests a significant degree of mosaicism. Also, the stringency of our method for quantitation of SRF protein in VEC may result in an underestimation of the number of cells displaying detectable SRF protein. We have observed varying degrees of Srf-floxed allele excision efficiency based on the Cre recombinase driver, as well as possible variability from cell to cell. This results in a mosaic expression pattern between individual cells; however, the phenotypic effects of the excision still manifest in the tissue as a whole. Nevertheless, it is likely that more complete ablation may result in a more severe phenotype.
###end p 56
###begin p 57
###xml 1183 1185 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Yolk sac vascular networks undergo extensive remodelling during the course of embryogenesis. In our study, yolk sac vascular networks appear to form normally, echoing what was observed in initial coronary vessel development. However, yolk sac vascular networks became severely disrupted by E12.5, indicating a failure of the blood vessels to remodel and mature. Disintegration of yolk sac vasculature was accompanied by separation of endodermal and mesodermal cell layers. Further analysis revealed a lack of desmosomal junctions and intralaminar collagen as well as dramatic loss of E-cadherin in cells of the endodermal layer. Anchoring-type desmosomal junctions are plentiful in tissues subject to persistent mechanical stress, such as yolk sac, skin, and heart. Proper junction formation relies on appropriate expression of cytoskeletal and cell surface anchoring proteins such as actins, cadherins, and integrins. Recent work in our laboratory has shown that SRF-null cardiomyocytes have decreased levels of a number of genes associated with cell adhesion and cytoskeletal function including integrins beta1 and alpha9, tight junction protein ZO-1, and protocadherins 7 and 18 [10], raising the possibility that the same genes may be affected in SRF-null endothelial cells, resulting in deficient cell-cell contacts.
###end p 57
###begin p 58
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 481 483 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Previous research has shown cadherins are also required for pericyte-endothelial interactions during angiogenic sprouting [31]. Furthermore, VE-cadherin, a major component of adherens junctions between endothelial cells, has been shown to promote angiogenesis [32]. Consistent with these findings, putative SRF-binding sites have been identified in the VE-cadherin-2/protocadherin12 [33], integrin-beta1, integrin-beta1 binding protein 2, protocadherin7 and protocadherin18 genes [10]. These observations suggest the involvement of SRF in regulation of cell-cell contacts; however as of yet, no experimental studies have addressed whether SRF is a significant player in these interactions, or whether SRF is a regulator of these genes in VEC.
###end p 58
###begin p 59
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1214 1216 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
Our results also raise the possibility that SRF may play a role in periendothelial cell/pericyte recruitment and vessel stabilization via involvement in angiopoietin (Ang) signalling. PECAM staining of yolk sac from Ang1-null mice shows a loss of vascular integrity similar to that seen in our study [34]. Ang1, a member of the angiopoietin family of ligands [25], activates the Tie2 receptor by binding to it and inducing its tyrosine phosphorylation. Ang1 is generated by non-endothelial cells, such as VSMC and other vascular pericytes recruited to vessels. Early in development between E9 to E11, Ang1 is found most prominently in the heart myocardium surrounding the endocardium. Later, it becomes more widely distributed, most often detected in the mesenchyme surrounding developing vessels and in close association with endothelial cells. Ang1-dependent vessel stabilization occurs by supporting reciprocal interactions between the vascular endothelium, pericytes, and surrounding extracellular matrix and mesenchyme [35]. Tie2 mediates Ang1 signalling via several known signalling pathways, including the Akt, RhoA/Rac1, MAPK, and ERK1/2 pathways [25]. Since SRF is a known mediator of all these pathways [36-39], this suggests that a role for SRF in Tie-2 mediated angiogenic remodelling may also lie as a downstream effector in the Ang1/2 signalling cascade in endothelial cells.
###end p 59
###begin p 60
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 341 349 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
The results presented here unequivocally establish SRF as a critical regulator of endothelial cell function in vivo and indicate that appropriate SRF protein expression is required for remodelling of vascular networks. However, these results do not directly address the role of SRF in endothelial specification and differentiation since the Tie2Cre construct is expressed in differentiated endothelial cells. Our results suggest that disruption of anchoring-type proteins may play a significant role in the observed vascular failure, although the precise underlying molecular mechanisms remain to be addressed. Development of reagents that allow functional analyses of SRF loss of in endothelial precursors as well as vessel maturation will be required to more fully address these questions.
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 123 128 <span type="species:ncbi:10090">Mouse</span>
Our study provides the first in vivo experimental evidence of a role for SRF in VEC function during embryonic development. Mouse embryos lacking SRF expression in endothelial cells die mid-gestation due to apparent vascular insufficiency. Initial analysis suggests a lethal malfunction in angiogenic remodelling and vessel maintenance. The extent to which this malfunction is due to failed reciprocal signalling between VEC and surrounding mesenchyme or perhaps incomplete vascular pericyte recruitment remains to be determined.
###end p 62
###begin title 63
Methods
###end title 63
###begin title 64
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and Genotyping
###end title 64
###begin p 65
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 19 20 19 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 21 23 21 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 19 23 19 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 569 577 569 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre </italic>
###xml 648 651 648 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 653 655 653 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 651 655 651 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 723 728 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT </italic>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
The Tie2Cre and Srff/f transgenic mouse lines have been previously described [27,40]. Previous work has demonstrated that expression of the Tie2Cre gene begins early at E7.5; expression has been noted in all endothelial and endocardial tissues as well as some hematopoietic tissues [27]. Embryos were generated by timed mating, designating embryonic day 0.5 (E0.5) as noon on the day a vaginal plug was observed. Genotyping was performed under standard protocols using genomic DNA isolated from embryonic yolk sac, amnionic membrane, or tail tissue. Primers used were: Tie2Cre fwd 5'-GTTCGCAAGAACCTGATGGACA-3' and rev 5'-CTAGAGCCTGTTTTGCACGTTC-3'; Srff/f fwd 5'-TGCTTACTGGAAAGCTCATGG-3' and rev 5'-TGCTGGTTTGGmCATCAACT-3'; HPRT fwd 5'-AGCGCAAGTTGAATCTGC-3' and rev 5'-AGCGACAATCTACCAGAG-3'. All procedures were in compliance with the Institutional Animal Care and Use Committee of the Medical College of Wisconsin.
###end p 65
###begin title 66
Quantitation of embryonic total body and isolated heart weights
###end title 66
###begin p 67
Embryos were harvested from timed pregnant females and placed individually on a clean glass slide for weight determination; excess buffer fluid was absorbed by wicking with tissues prior to weighing. After whole body weight was recorded, the heart was dissected out and weighed separately. Amnionic membrane was reserved for genotypic analysis.
###end p 67
###begin title 68
Histology, Immunohistochemistry, and Microscopy
###end title 68
###begin p 69
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 642 644 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 645 647 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
Embryos were harvested from timed pregnant females, photographed, and then fixed in either 4% paraformaldehyde/PBS or Tris-buffered zinc fixative (0.1 M Tris pH7.4 with 3.2 mM calcium acetate, 22.8 mM zinc acetate, and 36.7 mM zinc chloride). Yolk sac tissues selected for whole mount immunostaining were processed as described [41]. After staining, tissues were photographed and further processed for paraffin-embedding. All other samples were processed for paraffin-embedding, and subsequent sections (7 mum) were used for either hematoxylin & eosin staining, alcian blue staining, immunohistochemistry or confocal microscopy as described [42,43]. Reagents utilized were: anti-E-cadherin (BD Bioscience, clone 36); anti-sarcomeric myosin (University of Iowa Developmental Studies Hybridoma Bank, clone MF-20); anti-PECAM-1 (BD Biosciences, clone MEC13.3); anti-phospho-Histone H3 (Millipore, Ser-10); anti-SRF (ProteinTech custom). Digital image capture was performed using a Nikon SM2100 microscope with a Nikon CoolPix995 camera (whole mount), Nikon Eclipse TE300 microscope with a SpotII digital camera (tissue sections), or a Leica TCS SP2 laser scanning confocal microscope imaging system (confocal imaging). For electron microscopy, embryos were harvested from timed pregnant females and fixed in glutaraldehyde/sodium arsenate buffer. Subsequent processing and image collection were performed by the Electron Microscopy Core Facility at the Medical College of Wisconsin.
###end p 69
###begin title 70
Authors' contributions
###end title 70
###begin p 71
MLH and RPM contributed equally to this project.
###end p 71
###begin title 72
Supplementary Material
###end title 72
###begin title 73
Additional file 1
###end title 73
###begin p 74
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f/f </italic>
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f/f </italic></sup>
###xml 0 135 0 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mitotic marker phospho Histone H3 appears decreased in <italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f/f </italic></sup>endocardial endothelial cells compared to wild-type littermates</bold>
###xml 576 583 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 583 586 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 586 589 586 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 589 593 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f/f </italic>
###xml 589 593 589 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f/f </italic></sup>
###xml 1222 1233 1222 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circ. Res. </italic>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
Mitotic marker phospho Histone H3 appears decreased in Tie2Cre+/-Srff/f endocardial endothelial cells compared to wild-type littermates. Single-plane confocal images (630x) of sections of E11.5 mouse embryonic ventricular tissue (A, B) immunostained for endocardial endothelial cells (PECAM-1; red), cardiomyocytes (MF-20; green), and proliferating cells (phospho Histone H3, PhH3; blue). (C) Quantitation of PhH3-positive nuclei in either endocardial endothelial cells or cardiomyocytes (total PhH3-positive cells immunolabelled by PECAM-1 or MF-20 over four visual fields). Tie2Cre+/-Srff/f mutant embryos exhibited reduced PhH3 immunoreactivity in endocardial endothelial cells compared to wild-type embryos, indicating a decrease in proliferation (arrowheads; C, left graph). MF-20-positive cardiomyocytes in mutant tissue exhibit a mild decrease in PhH3 immunostaining (arrows; C, right graph), which is consistent with the apparent reduction in overall myocardial size. Decreased myocardial mass is likely a secondary effect of inadequate signalling from SRF-null endocardial endothelial cells rather than Cre-mediated direct excision of SRF in cardiomyocytes. Also, consistent with previous reports (Nelson et al., Circ. Res. 2004), presumed epicardium is negative for PECAM-1 staining in both wild-type and mutant embryos (asterisks). Scale bar: A, B = 30 mum.
###end p 74
###begin p 75
Click here for file
###end p 75
###begin title 76
Additional file 2
###end title 76
###begin p 77
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 74 76 74 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 0 184 0 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fewer endocardial endothelial cells express SRF protein in <italic>Tie2Cre</italic><sup>+/-</sup><italic>Srf</italic><sup><italic>f</italic>/<italic>f </italic></sup>embryos compared to wild-type littermates, however the number of SRF-positive cardiomyocytes remains similar</bold>
###xml 587 594 587 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tie2Cre</italic>
###xml 594 597 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 597 600 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf</italic>
###xml 600 601 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 602 604 602 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 600 604 600 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic>/<italic>f </italic></sup>
###xml 1259 1263 1259 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf </italic>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
Fewer endocardial endothelial cells express SRF protein in Tie2Cre+/-Srff/f embryos compared to wild-type littermates, however the number of SRF-positive cardiomyocytes remains similar. Single-plane confocal images (630x) of E11.5 mouse embryonic ventricular tissue (A, B) immunostained for endocardial endothelial cells (PECAM-1; red), cardiomyocytes (MF-20; green), and SRF (blue). (C) Number of SRF-positive nuclei in either endocardial endothelial cells or cardiomyocytes (total SRF-positive nuclei in either endocardial endothelial cells or cardiomyocytes over four visual fields). Tie2Cre+/-Srff/f mutant embryos exhibited a reduced number of SRF-labelled nuclei in endocardial endothelial cells, consistent with a decrease in proliferation (arrowheads; C, right graph). MF-20-positive cardiomyocytes in mutant tissue exhibit virtually no change in SRF-labelled nuclei (arrows; C, left graph). These results are consistent with a signalling defect in SRF-null endocardial endothelial cells, and raise the possibility that the decrease in myocardial mass observed in mutant embryos may be related to inadequate reciprocal signalling between endocardial endothelial cells and the underlying myocardium rather than from Cre-mediated direct excision of the Srf gene in cardiomyocytes. Scale bar: 30 mum.
###end p 77
###begin p 78
Click here for file
###end p 78
###begin title 79
Acknowledgements
###end title 79
###begin p 80
We thank Dr. Mark Majesky and Dr. Simon Conway for valuable discussions, Dr. Alexandra Lerch-Gaggl and the Bryant Imaging Core Facility at MCW for assistance with confocal imagery, and Mr. Clive Wells of the Electron Microscopy Core Facility at MCW for assistance and expertise in electron microscopy. This work was supported by grants HL67272 and HL084636 to R.P.M. from the National Institutes of Health; and a grant from Sophia Wolf Quadracci Memorial Fund for Stem Cell Research to R.P.M.
###end p 80
###begin article-title 81
Serum response factor: toggling between disparate programs of gene expression.
###end article-title 81
###begin article-title 82
The serum response element
###end article-title 82
###begin article-title 83
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Serum response factor is essential for mesoderm formation during mouse embryogenesis
###end article-title 83
###begin article-title 84
Actin' together: serum response factor, its cofactors and the link to signal transduction.
###end article-title 84
###begin article-title 85
###xml 54 60 <span type="species:ncbi:10090">murine</span>
Organization and myogenic restricted expressin of the murine serum response factor gene. A role for autoregulation.
###end article-title 85
###begin article-title 86
###xml 66 71 <span type="species:ncbi:9606">human</span>
Identification and characterization of a factor that binds to two human sarcomeric actin promoters
###end article-title 86
###begin article-title 87
The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor
###end article-title 87
###begin article-title 88
New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways
###end article-title 88
###begin article-title 89
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice.
###end article-title 89
###begin article-title 90
Role of the serum response factor in regulating contractile apparatus gene expression and sarcomeric integrity in cardiomyocytes
###end article-title 90
###begin article-title 91
Restricted inactivation of serum response factor to the cardiovascular system
###end article-title 91
###begin article-title 92
Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart.
###end article-title 92
###begin article-title 93
Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality.
###end article-title 93
###begin article-title 94
Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation
###end article-title 94
###begin article-title 95
Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins
###end article-title 95
###begin article-title 96
Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes.
###end article-title 96
###begin article-title 97
Retroviral analysis of cardiac morphogenesis: discontinuous formation of coronary vessels
###end article-title 97
###begin article-title 98
Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ.
###end article-title 98
###begin article-title 99
Smooth muscle cells and fibroblasts of the coronary arteries derive from epithelial-mesenchymal transformation of the epicardium
###end article-title 99
###begin article-title 100
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Origin and development of the epicardium in the mouse embryo
###end article-title 100
###begin article-title 101
Conserved enhancer in the serum response factor promoter controls expression during early coronary vasculogenesis.
###end article-title 101
###begin article-title 102
A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells
###end article-title 102
###begin article-title 103
A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages
###end article-title 103
###begin article-title 104
Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis
###end article-title 104
###begin article-title 105
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
###end article-title 105
###begin article-title 106
###xml 87 102 <span type="species:ncbi:10090">transgenic mice</span>
Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice
###end article-title 106
###begin article-title 107
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo
###end article-title 107
###begin article-title 108
Signals from both sides: Control of cardiac development by the endocardium and epicardium
###end article-title 108
###begin article-title 109
The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts
###end article-title 109
###begin article-title 110
###xml 87 94 <span type="species:ncbi:9031">chicken</span>
N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken
###end article-title 110
###begin article-title 111
Architecture of the VE-cadherin hexamer
###end article-title 111
###begin article-title 112
Defining the mammalian CArGome
###end article-title 112
###begin article-title 113
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
###end article-title 113
###begin article-title 114
###xml 119 123 <span type="species:ncbi:10090">mice</span>
Abnormal recruitment of periendothelial cells to lymphatic capillaries in digestive organs of angiopoietin-2-deficient mice
###end article-title 114
###begin article-title 115
###xml 32 35 <span type="species:ncbi:9860">Elk</span>
ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation
###end article-title 115
###begin article-title 116
Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors
###end article-title 116
###begin article-title 117
Integration of MAP kinase signal transduction pathways at the serum response element
###end article-title 117
###begin article-title 118
SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation
###end article-title 118
###begin article-title 119
SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability
###end article-title 119
###begin article-title 120
Effect of ethanol on the development of visceral yolk sac
###end article-title 120
###begin article-title 121
Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver
###end article-title 121
###begin article-title 122
Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis
###end article-title 122

